Evidence Based Healthcare 回想一下
... From 1997 to 2000, review of 167 original reports of randomized trials (with a total of 300276 patients) that included a composite primary outcome that incorporated all-cause mortality ...
... From 1997 to 2000, review of 167 original reports of randomized trials (with a total of 300276 patients) that included a composite primary outcome that incorporated all-cause mortality ...
Slide 1
... A Syndrome of Epidemic Proportions • Approximately 4.9 million cases in the United States today • Over 400,000 new cases per year • The most common cause of hospitalization in people over 65 years • Increasing numbers of CHF patients due to the aging population ...
... A Syndrome of Epidemic Proportions • Approximately 4.9 million cases in the United States today • Over 400,000 new cases per year • The most common cause of hospitalization in people over 65 years • Increasing numbers of CHF patients due to the aging population ...
Atherosclerosis
... cardiomegaly due to pre-existing myocardial damage. () Echocardiography : • This is useful for assessing left and right ventricular function and for detecting important complications such as mural thrombus, cardiac rupture, ventricular septal defect, mitral regurgitation and pericardial effusion. ...
... cardiomegaly due to pre-existing myocardial damage. () Echocardiography : • This is useful for assessing left and right ventricular function and for detecting important complications such as mural thrombus, cardiac rupture, ventricular septal defect, mitral regurgitation and pericardial effusion. ...
Chronic heart failure with preserved ejection fraction: The modern
... diuretics improve symptoms is similar across the spectrum of left ventricular ejection fraction [14]. Evidence that betablockers and MRAs improve symptoms in CHFpEF patients is lacking. There is inconsistent evidence for an improvement in symptoms in those treated with ARBs (only for candesartan was ...
... diuretics improve symptoms is similar across the spectrum of left ventricular ejection fraction [14]. Evidence that betablockers and MRAs improve symptoms in CHFpEF patients is lacking. There is inconsistent evidence for an improvement in symptoms in those treated with ARBs (only for candesartan was ...
rdw correlates with left atrial dimension and lvedp in catheterized
... Background: RDW is an independent prognostic factor in patients with congestive heart failure. In this population, High RDW is also associated with higher prevalence of atrial fibrillation. Based on this observation, we sought to see if RDW is correlated with LVEDP, LAD, and pulmonary artery pressur ...
... Background: RDW is an independent prognostic factor in patients with congestive heart failure. In this population, High RDW is also associated with higher prevalence of atrial fibrillation. Based on this observation, we sought to see if RDW is correlated with LVEDP, LAD, and pulmonary artery pressur ...
Current Therapy for Hypertension and What the Future May Hold for
... ~ 5% of patients with HTN have identifiable causes Suspect in patients who develop HTN at an early age, who first exhibit HTN when over age 50, or those who were well controlled but became refractory to treatment ...
... ~ 5% of patients with HTN have identifiable causes Suspect in patients who develop HTN at an early age, who first exhibit HTN when over age 50, or those who were well controlled but became refractory to treatment ...
SHORTNESS OF BREATH WITHOUT CHEST PAIN - Cedars
... blocked coronary arteries. During the test, patients exercise on a treadmill or, if they can’t, are given medication that causes the heart’s arteries to dilate. Once the patient reaches “peak” stress, a small amount of radioactive imaging agent is given that concentrates in the heart according to bl ...
... blocked coronary arteries. During the test, patients exercise on a treadmill or, if they can’t, are given medication that causes the heart’s arteries to dilate. Once the patient reaches “peak” stress, a small amount of radioactive imaging agent is given that concentrates in the heart according to bl ...
The Importance of Heart Rate in Coronary Artery
... deprives the heart muscle of oxygen. Depending on the severity of atherosclerosis, it can manifest clinically as angina or heart attack (myocardial infarction). This could lead to insufficient heart muscle function, or even death of heart muscle, resulting in congestive heart failure. Slowing the he ...
... deprives the heart muscle of oxygen. Depending on the severity of atherosclerosis, it can manifest clinically as angina or heart attack (myocardial infarction). This could lead to insufficient heart muscle function, or even death of heart muscle, resulting in congestive heart failure. Slowing the he ...
Cardiac Pathophysiology
... • The arteries that supply the heart are the first branches off the aorta • Coronary artery disease decreases the blood flow to the cardiac muscle. • Persistent ischemia or complete occlusion leads to hypoxia. • Hypoxia can cause tissue death or infarction, which is a “heart attack,” which accounts ...
... • The arteries that supply the heart are the first branches off the aorta • Coronary artery disease decreases the blood flow to the cardiac muscle. • Persistent ischemia or complete occlusion leads to hypoxia. • Hypoxia can cause tissue death or infarction, which is a “heart attack,” which accounts ...
Electrocardiography - Westchester Medical Center
... Electrocardiography is a commonly used, noninvasive procedure for recording electrical changes in the heart. The record, which is called an electrocardiogram (ECG or EKG), shows the series of waves that relate to the electrical impulses which occur during each beat of the heart. An ECG is performed ...
... Electrocardiography is a commonly used, noninvasive procedure for recording electrical changes in the heart. The record, which is called an electrocardiogram (ECG or EKG), shows the series of waves that relate to the electrical impulses which occur during each beat of the heart. An ECG is performed ...
Bypassing the emergency room to reduce door-to-
... percutaneous coronary intervention can achieve superior outcomes compared with fibrinolysis in the treatment of STEMI [4] and recent guidelines recommend primary PCI as the preferred reperfusion strategy in STEMI patients [5]. It was previously shown that a delay in door-to-balloon time of more than ...
... percutaneous coronary intervention can achieve superior outcomes compared with fibrinolysis in the treatment of STEMI [4] and recent guidelines recommend primary PCI as the preferred reperfusion strategy in STEMI patients [5]. It was previously shown that a delay in door-to-balloon time of more than ...
061302 Cardiac-Resynchronization Therapy for Heart Failure
... as left or right bundle-branch block, leading to loss of coordination of ventricular contraction.7 This dyssynchronous pattern of ventricular contraction is believed to contribute to the pathophysiology of heart failure, reducing the already diminished contractile reserve of the heart.8 Specifically ...
... as left or right bundle-branch block, leading to loss of coordination of ventricular contraction.7 This dyssynchronous pattern of ventricular contraction is believed to contribute to the pathophysiology of heart failure, reducing the already diminished contractile reserve of the heart.8 Specifically ...
Modifying Coronary Artery Atherosclerosis : Dr Thomas Challenger
... stuff (i.e., it did not appear to adversely affect blood pressure). It did nothing to LDL-C or apoB. This study, called dal-OUTCOMES, was similar to the other trials in that patients were randomized to either standard of care plus placebo or standard of care plus escalating doses of dalcetrapib. A r ...
... stuff (i.e., it did not appear to adversely affect blood pressure). It did nothing to LDL-C or apoB. This study, called dal-OUTCOMES, was similar to the other trials in that patients were randomized to either standard of care plus placebo or standard of care plus escalating doses of dalcetrapib. A r ...
ABS HF CTR presentation 1
... Time from presentation (days) Ejection fraction (%) Wall motion score index ...
... Time from presentation (days) Ejection fraction (%) Wall motion score index ...
Anatomy and Physiology for Emergency Care
... Physiology for Emergency Care Chapter 13 The Heart ...
... Physiology for Emergency Care Chapter 13 The Heart ...
Levosimendan pre-treatment improves outcomes in - Area
... The first cardioplegia infusion was given antegradely via an aortic root cannula for 2 min, and then retrograde cardioplegia was given for a further 2 min. The potassium concentration of the induction cardioplegia was 20 mmol litre21. After each distal anastomosis, additional cardioplegic solution w ...
... The first cardioplegia infusion was given antegradely via an aortic root cannula for 2 min, and then retrograde cardioplegia was given for a further 2 min. The potassium concentration of the induction cardioplegia was 20 mmol litre21. After each distal anastomosis, additional cardioplegic solution w ...
Cardiogenic Shock searching for the recent
... • CHF awaiting cardiac transplatation, undergoing CPB • Cardiac and vascular profile similar to other PDE III inhibitor ...
... • CHF awaiting cardiac transplatation, undergoing CPB • Cardiac and vascular profile similar to other PDE III inhibitor ...
DoInhaledLevalbuterol
... study population had either asthma or chronic obstructive pulmonary disease (COPD). Compared with placebo, beta-2-agonists were associated with a 2.5 relative risk (95% CI, 1.69–4.1) for adverse cardiovascular events (P<.001). While most of these events were sinus tachycardia (RR=3.1; 95% CI, 1.7–5. ...
... study population had either asthma or chronic obstructive pulmonary disease (COPD). Compared with placebo, beta-2-agonists were associated with a 2.5 relative risk (95% CI, 1.69–4.1) for adverse cardiovascular events (P<.001). While most of these events were sinus tachycardia (RR=3.1; 95% CI, 1.7–5. ...
Agents That Dilate Coronary Blood Vessels
... The primary cause of ischemic heart disease is coronary artery disease (CAD) Results ...
... The primary cause of ischemic heart disease is coronary artery disease (CAD) Results ...
Project Description
... General Explanation of the Study This data is from a study that was trying to determine if a drug called "dobutamine" could be used effectively in a test for measuring a patient's risk of having a heart attack, or "cardiac event." For younger patients, a typical test of this risk is called "Stress E ...
... General Explanation of the Study This data is from a study that was trying to determine if a drug called "dobutamine" could be used effectively in a test for measuring a patient's risk of having a heart attack, or "cardiac event." For younger patients, a typical test of this risk is called "Stress E ...
Non-cardiac surgery in the heart failure patient - Heart
... surgery and the patient’s cardiac status, respectively.4 The medical score provided significantly better risk prediction for adverse perioperative cardiac events than the surgical score. A high medical score identified 87% of those who suVered a cardiac event, while a high surgical risk score identi ...
... surgery and the patient’s cardiac status, respectively.4 The medical score provided significantly better risk prediction for adverse perioperative cardiac events than the surgical score. A high medical score identified 87% of those who suVered a cardiac event, while a high surgical risk score identi ...
PowerPoint-Präsentation - Clinical Trial Results
... By intention-to-treat, biolimus-eluting BP-DES were non-inferior to everolimus-eluting DP-DES after 2 years in a real-world population of patients in need for large-vessel stenting. Both DES were superior in efficacy (TVR ) to thin-strut BMS. There was no evidence for a better safety, particul ...
... By intention-to-treat, biolimus-eluting BP-DES were non-inferior to everolimus-eluting DP-DES after 2 years in a real-world population of patients in need for large-vessel stenting. Both DES were superior in efficacy (TVR ) to thin-strut BMS. There was no evidence for a better safety, particul ...
Anticoagulation in Patients with Dilated Cardiomyopathy, Low
... Several prospective randomized trials were either underpowered or had a short period of follow-up. The Heart Failure Long-Term Antithrombotic Study (HELAS) enrolled 197 patients with EF<35% of ischemic and idiopathic etiology, randomized to receive warfarin, aspirin, or placebo; no overall significa ...
... Several prospective randomized trials were either underpowered or had a short period of follow-up. The Heart Failure Long-Term Antithrombotic Study (HELAS) enrolled 197 patients with EF<35% of ischemic and idiopathic etiology, randomized to receive warfarin, aspirin, or placebo; no overall significa ...
Drug-Free Correction of the Tone of the Autonomic Nervous System
... Methods: A decrease in sympathetic tone was achieved via vagus nerve electrical stimulation (VNES). VNES was performed in 48 male CAD patients, mean age 53.5±4.1 years. Antiarrhythmic drug therapy was canceled prior to VNES therapy. The effect of VNES on heart rate variability (HRV) and VES were car ...
... Methods: A decrease in sympathetic tone was achieved via vagus nerve electrical stimulation (VNES). VNES was performed in 48 male CAD patients, mean age 53.5±4.1 years. Antiarrhythmic drug therapy was canceled prior to VNES therapy. The effect of VNES on heart rate variability (HRV) and VES were car ...
Therapeutic Angiogenesis for Ischemic Heart Disease
... procedures. Consequently, many of these patients have persistent symptoms of myocardial ischemia despite intensive medical therapy. The discovery of candidate molecules able to stimulate myocardial angiogenesis has stirred a growing interest in using these molecules for therapeutic application.1) Pr ...
... procedures. Consequently, many of these patients have persistent symptoms of myocardial ischemia despite intensive medical therapy. The discovery of candidate molecules able to stimulate myocardial angiogenesis has stirred a growing interest in using these molecules for therapeutic application.1) Pr ...